Patent details

EP2889033 Title: Treatment of negative symptoms of schizophrenia with (R)-7-chloro-N-(quinuclidin-3-yl)benzo[b]thiophene-2-carboxamide and pharmaceutically acceptable salts thereof

Basic Information

Publication number:
EP2889033
PCT Application Number:
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP151511656
PCT Publication Number:
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
Treatment of negative symptoms of schizophrenia with (R)-7-chloro-N-(quinuclidin-3-yl)benzo[b]thiophene-2-carboxamide and pharmaceutically acceptable salts thereof
French Title of Invention:
Traitement de symptômes négatifs de la schizophrénie avec (R)-7-chloro-N-(quinuclidin-3-yl)benzo[b]thiophene-2-carboxamide et leurs sels pharmaceutiquement acceptables
German Title of Invention:
Behandlung von negativen Symptomen der Schizophrenie mit (R)-7-Chlor-N-(quinuclidin-3-yl)benzo[b]thiophen-2-carboxamid und pharmazeutisch verträgliche Salze davon
SPC Number:

Dates

Filing date:
19/11/2009
Grant date:
21/03/2018
EP Publication Date:
01/07/2015
PCT Publication Date:
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
21/03/2018
EP B1 Publication Date:
21/03/2018
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
19/11/2020
Expiration date:
19/11/2029
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
14/03/2018
 
 

Name:
Forum Pharmaceuticals Inc.
Address:
225 Second Avenue, Waltham, MA 02451, United States (US)

Agent

Name:
ARONOVA S.A.
From:
20/06/2018
Address:
PO Box 327, 4004, ESCH-SUR-ALZETTE, Luxembourg (LU)
To:

Inventor

1

Name:
Shapiro, Gideon
Address:
United States (US)

2

Name:
Koenig, Gerhard
Address:
United States (US)

3

Name:
Chesworth, Richard
Address:
United States (US)

Priority

Priority Number:
116106 P
Priority Date:
19/11/2008
Priority Country:
United States (US)

Classification

IPC classification:
A61K 31/439; A61P 25/00;

Publication

European Patent Bulletin

Issue number:
201812
Publication date:
21/03/2018
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
18/09/2019
Last Annual Fee Paid Number:
11
Last Annual Fee Paid Amount:
148 Euro
Payer:
MASTER DATA CENTER INC (ex Clarivate Analytics)
Filing date Document type Number of pages
20/06/2018 Power Of Attorney 1